BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10450)

  • 1. Catecholamine metabolism in neuroblastoma.
    LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
    J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical activity in the metastatic lesions of neuroblastoma.
    Imashuku S; Takada H; Sawada T; Kusunoki T
    Clin Chim Acta; 1975 Aug; 63(1):1-5. PubMed ID: 241512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on tyrosine hydroxylase in neuroblastoma in relation to urinary levels of catecholamine metabolites.
    Imashuku S; Takada H; Sawada T; Nakamura T; LaBrosse EH
    Cancer; 1975 Aug; 36(2):450-7. PubMed ID: 239788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
    Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
    Piöchl E; Käser H; Klein H
    Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
    Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
    Lobo RA; Shoupe D; Roy S; Paul W
    Am J Obstet Gynecol; 1984 Jul; 149(5):548-52. PubMed ID: 6742025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
    Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
    Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Para-O-methylation of the catecholamines in neuroblastoma.
    Verheyden R; Ebinger G
    Clin Chim Acta; 1975 Jan; 58(2):181-4. PubMed ID: 1122641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and precursor availability affect urinary catecholamine metabolite production in women.
    Johnston JL; Warsh JJ; Anderson GH
    Am J Clin Nutr; 1983 Sep; 38(3):356-68. PubMed ID: 6613910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of Neuroblastoma Markers Homovanillic Acid (HVA) and Vanillylmandelic Acid (VMA) in Urine by Gas Chromatography-Mass Spectrometry (GC/MS).
    Beals M; Ramoo B; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():185-194. PubMed ID: 36127589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma.
    Brewster MA; Berry DH
    Med Pediatr Oncol; 1979; 6(2):93-9. PubMed ID: 460046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of norepinephrine secretion by dopamine in children with neuroblastoma: evidence for precursor inhibition in catecholamine pathway.
    Sato T; Minami S; Igarashi N; Miyagawa K
    Endocrinol Jpn; 1989 Aug; 36(4):595-603. PubMed ID: 2583066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
    Davidson DF; Hammond PJ; Murphy D; Carachi R
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic and dopaminergic response to chronic chair restraint in the rhesus monkey.
    Perlow MJ; Karoum F; Braun D; Wyatt RJ
    Psychosom Med; 1979 Mar; 41(2):139-45. PubMed ID: 108755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
    Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
    Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of 4-O-methylated catecholamine metabolites in urine by mass fragmentography.
    Muskiet FA; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG
    Clin Chem; 1979 Oct; 25(10):1708-13. PubMed ID: 476919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.